Baxter - 41 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1984 adjusted for splits and dividends. The latest closing stock price for Baxter as of April 04, 2025 is 28.79.
- The all-time high Baxter stock closing price was 84.94 on April 20, 2020.
- The Baxter 52-week high stock price is 42.86, which is 48.9% above the current share price.
- The Baxter 52-week low stock price is 28.34, which is 1.6% below the current share price.
- The average Baxter stock price for the last 52 weeks is 34.81.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 32.5588 | 29.1183 | 36.5700 | 28.7900 | 28.7900 | -0.79% |
| 2024 | 36.2117 | 37.5770 | 42.6333 | 28.4913 | 29.0188 | -22.40% |
| 2023 | 38.9772 | 47.9480 | 49.3853 | 30.4266 | 37.3932 | -21.91% |
| 2022 | 62.6542 | 80.2017 | 82.5837 | 46.6986 | 47.8823 | -39.58% |
| 2021 | 73.9338 | 72.9431 | 80.4972 | 67.6085 | 79.2508 | 8.48% |
| 2020 | 76.1132 | 77.2857 | 84.9437 | 64.5785 | 73.0524 | -2.93% |
| 2019 | 71.3547 | 58.1523 | 80.5892 | 57.4220 | 75.2607 | 28.40% |
| 2018 | 61.8884 | 59.1999 | 69.0905 | 54.6685 | 58.6153 | 2.89% |
| 2017 | 50.8780 | 38.7647 | 58.0699 | 38.7647 | 56.9701 | 47.30% |
| 2016 | 38.0659 | 32.0498 | 42.7574 | 29.9718 | 38.6775 | 17.58% |
| 2015 | 32.1100 | 34.1302 | 36.1046 | 27.7404 | 32.8948 | -3.59% |
| 2014 | 33.6474 | 32.2121 | 35.8481 | 30.9551 | 34.1209 | 5.38% |
| 2013 | 32.2885 | 31.4951 | 34.6516 | 29.7446 | 32.3797 | 4.34% |
| 2012 | 27.0152 | 23.5293 | 32.0351 | 22.8264 | 31.0342 | 34.72% |
| 2011 | 25.3039 | 23.5340 | 29.0555 | 22.1839 | 23.0359 | -2.25% |
| 2010 | 23.2315 | 27.1374 | 28.7296 | 18.8411 | 23.5666 | -13.74% |
| 2009 | 25.1501 | 25.6429 | 28.1662 | 21.6065 | 27.3189 | 9.50% |
| 2008 | 28.6063 | 26.9045 | 33.1244 | 22.5795 | 24.9492 | -7.68% |
| 2007 | 25.5032 | 21.6483 | 28.4408 | 21.5692 | 27.0255 | 25.13% |
| 2006 | 19.0578 | 17.8587 | 21.9789 | 16.5039 | 21.5971 | 23.21% |
| 2005 | 17.3506 | 16.1175 | 19.0645 | 15.5356 | 17.5282 | 9.00% |
| 2004 | 14.6572 | 14.0458 | 16.1036 | 13.3894 | 16.0803 | 13.17% |
| 2003 | 12.3737 | 13.3568 | 14.5253 | 8.6407 | 14.2087 | 9.00% |
| 2002 | 20.0860 | 24.7209 | 27.7470 | 11.2757 | 13.0355 | -47.79% |
| 2001 | 22.5455 | 20.8627 | 25.8383 | 18.9713 | 24.9677 | 21.46% |
| 2000 | 16.5199 | 13.6685 | 20.6881 | 11.5389 | 20.5571 | 46.96% |
| 1999 | 14.5746 | 14.0722 | 16.9116 | 13.0700 | 13.9886 | -2.33% |
| 1998 | 12.7584 | 11.1631 | 14.6985 | 10.8429 | 14.3227 | 27.51% |
| 1997 | 11.1944 | 9.0474 | 13.3762 | 9.0474 | 11.2327 | 23.02% |
| 1996 | 9.1912 | 8.5524 | 10.3001 | 8.2185 | 9.1309 | 6.13% |
| 1995 | 7.3104 | 5.7787 | 8.7322 | 5.5732 | 8.6038 | 48.23% |
| 1994 | 5.2500 | 5.0082 | 5.8814 | 4.5202 | 5.8043 | 15.90% |
| 1993 | 5.5383 | 6.5491 | 6.5491 | 4.1606 | 5.0082 | -24.71% |
| 1992 | 6.7514 | 7.3002 | 7.4629 | 5.7193 | 6.6519 | -10.59% |
| 1991 | 6.2920 | 5.0915 | 7.5094 | 4.7661 | 7.4397 | 43.50% |
| 1990 | 4.5801 | 4.7428 | 5.3938 | 3.8361 | 5.1845 | 11.50% |
| 1989 | 3.9985 | 3.2781 | 4.7661 | 3.2781 | 4.6498 | 41.84% |
| 1988 | 3.8526 | 4.3476 | 4.8126 | 3.0689 | 3.2781 | -22.53% |
| 1987 | 4.5066 | 3.5339 | 5.4170 | 3.4176 | 4.2313 | 18.18% |
| 1986 | 3.3760 | 2.8829 | 3.9291 | 2.8364 | 3.5804 | 22.22% |
| 1985 | 2.7166 | 2.4412 | 3.0921 | 2.3249 | 2.9294 | 20.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.557B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| ResMed (RMD) | United States | $32.876B | 25.32 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |